Related references
Note: Only part of the references are listed.Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia
Sylvie Giuriato et al.
BLOOD (2010)
Matrix Metalloproteinase-9 Is Upregulated in Nucleophosmin-Anaplastic Lymphoma Kinase-Positive Anaplastic Lymphomas and Activated at the Cell Surface by the Chaperone Heat Shock Protein 90 to Promote Cell Invasion
Frederic Lagarrigue et al.
CANCER RESEARCH (2010)
ALK fusion genes in children with atypical myeloproliferative leukemia
S. Roettgers et al.
LEUKEMIA (2010)
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
Young Lim Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Anaplastic Lymphoma Kinase Controls Cell Shape and Growth of Anaplastic Large Cell Lymphoma through Cdc42 Activation
Chiara Ambrogio et al.
CANCER RESEARCH (2008)
Mammalian Rho GTPases:: new insights into their functions from in vivo studies
Sarah J. Heasman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy
Rongshi Li et al.
MEDICINAL RESEARCH REVIEWS (2008)
Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas
A. Colomba et al.
ONCOGENE (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease
Emily K. Thomas et al.
CANCER CELL (2007)
Pathobiology of ALK+ anaplastic large-cell lymphoma
Hesham M. Amin et al.
BLOOD (2007)
'Normal counterparts' of nodal peripheral T-cell lymphoma
Thomas Ruediger et al.
HEMATOLOGICAL ONCOLOGY (2006)
Proteomic analysis of anaplastic lymphoma cell lines: Identification of potential tumour markers
Daniel Cussac et al.
PROTEOMICS (2006)
Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells
SD Turner et al.
LEUKEMIA (2006)
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase
C Ambrogio et al.
BLOOD (2005)
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
R Chiarle et al.
NATURE MEDICINE (2005)
Identification of NPM-ALK interacting proteins by tandem mass spectrometry
DK Crockett et al.
ONCOGENE (2004)
Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells
F Armstrong et al.
ONCOGENE (2004)
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Y Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a 'small-cell variant' of ALCL
L Lamant et al.
LEUKEMIA (2004)
Share Paper
